{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:16:31Z","timestamp":1772165791724,"version":"3.50.1"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,7,16]],"date-time":"2021-07-16T00:00:00Z","timestamp":1626393600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,7,16]],"date-time":"2021-07-16T00:00:00Z","timestamp":1626393600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pediatr"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Biliary atresia (BA) is a severe cholangiopathy possibly resulting from virus-induced and immune-mediated injury of the biliary system. IFN-\u03b3, secreted from CD4\n                      <jats:sup>+<\/jats:sup>\n                      Th1 cells and CD8\n                      <jats:sup>+<\/jats:sup>\n                      cytotoxic T cells, is a major mediator of liver pathology. Programmed death protein-1 (PD-1) signaling suppresses T cell function. However, how PD-1 modify T cell function in BA remains incompletely understood.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Frequencies of PD-1 expressing CD4\n                      <jats:sup>+<\/jats:sup>\n                      and CD8\n                      <jats:sup>+<\/jats:sup>\n                      T cells were analyzed in the liver and blood from BA and control subjects. Associations of PD-1\n                      <jats:sup>+<\/jats:sup>\n                      CD4\n                      <jats:sup>+<\/jats:sup>\n                      \/CD8\n                      <jats:sup>+<\/jats:sup>\n                      T cell abundances with liver function indices were measured. Function of PD-1 was measured by administration of an anti-PD-1 antibody in a Rhesus Rotavirus (RRV)-induced BA model. Survival, histology, direct bilirubin, liver immune cell subsets and cytokine production were analyzed.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      PD-1 was significantly upregulated in CD4\n                      <jats:sup>+<\/jats:sup>\n                      and CD8\n                      <jats:sup>+<\/jats:sup>\n                      T cells in patients with BA compared with control subjects. PD-1 expression in T cells was negatively associated with IFN-\u03b3 concentration in liver (PD-1\n                      <jats:sup>+<\/jats:sup>\n                      CD4\n                      <jats:sup>+<\/jats:sup>\n                      T cells in liver vs. IFN-\u03b3 concentration,\n                      <jats:italic>r<\/jats:italic>\n                      \u00a0=\u2009\u2212\u20090.25,\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0=\u20090.05; PD-1\n                      <jats:sup>+<\/jats:sup>\n                      CD8\n                      <jats:sup>+<\/jats:sup>\n                      T cells in liver vs. IFN-\u03b3 concentration,\n                      <jats:italic>r<\/jats:italic>\n                      \u00a0=\u2009\u2212\u20090.39,\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0=\u20090.004). Blockade of PD-1 increased IFN-\u03b3 expression in CD4\n                      <jats:sup>+<\/jats:sup>\n                      T and CD8\n                      <jats:sup>+<\/jats:sup>\n                      T cells (RRV vs. anti-PD-1 treated RRV mice: 11.59\u2009\u00b1\u20093.43% vs. 21.26\u2009\u00b1\u20095.32% IFN-\u03b3\n                      <jats:sup>+<\/jats:sup>\n                      in hepatic CD4\n                      <jats:sup>+<\/jats:sup>\n                      T cells,\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0=\u20090.0003; 9.33\u2009\u00b1\u20094.03% vs. 22.55\u2009\u00b1\u20097.47% IFN-\u03b3\n                      <jats:sup>+<\/jats:sup>\n                      in hepatic CD8\n                      <jats:sup>+<\/jats:sup>\n                      T cells,\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0=\u20090.0001), suppressed bilirubin production (RRV vs. anti-PD-1 treated RRV mice: 285.4\u2009\u00b1\u200947.93 vs. 229.8\u2009\u00b1\u200945.86\u2009\u03bcmol\/L total bilirubin,\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0=\u20090.01) and exacerbated liver immunopathology.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>PD-1 plays a protective role in infants with BA by suppressing IFN-\u03b3 production in T cells. Increasing PD-1 signaling may serve as a therapeutic strategy for BA.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12887-021-02794-x","type":"journal-article","created":{"date-parts":[[2021,7,16]],"date-time":"2021-07-16T01:02:55Z","timestamp":1626397375000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Programmed cell death protein-1 (PD-1) protects liver damage by suppressing IFN-\u03b3 expression in T cells in infants and neonatal mice"],"prefix":"10.1186","volume":"21","author":[{"given":"Xuangjie","family":"Guo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiping","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rongli","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuxia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhe","family":"Wen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanhui","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,7,16]]},"reference":[{"issue":"6","key":"2794_CR1","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1038\/nrgastro.2015.74","volume":"12","author":"A Asai","year":"2015","unstructured":"Asai A, Miethke A, Bezerra JA. Pathogenesis of biliary atresia: defining biology to understand clinical phenotypes. Nat Rev Gastroenterol Hepatol. 2015;12(6):342\u201352.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"9702","key":"2794_CR2","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1016\/S0140-6736(09)60946-6","volume":"374","author":"JL Hartley","year":"2009","unstructured":"Hartley JL, Davenport M, Kelly DA. Biliary atresia. Lancet. 2009;374(9702):1704\u201313.","journal-title":"Lancet."},{"issue":"2","key":"2794_CR3","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1111\/petr.12040","volume":"17","author":"A Gallo","year":"2013","unstructured":"Gallo A, Esquivel CO. Current options for management of biliary atresia. Pediatr Transplant. 2013;17(2):95\u20138.","journal-title":"Pediatr Transplant"},{"issue":"1","key":"2794_CR4","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1067\/mpd.2001.115068","volume":"139","author":"JC Bucuvalas","year":"2001","unstructured":"Bucuvalas JC, Ryckman FC, Atherton H, Alonso MP, Balistreri WF, Kotagal U. Predictors of cost of liver transplantation in children: a single center study. J Pediatr. 2001;139(1):66\u201374.","journal-title":"J Pediatr"},{"issue":"3","key":"2794_CR5","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1055\/s-2007-985068","volume":"27","author":"CL Mack","year":"2007","unstructured":"Mack CL. The pathogenesis of biliary atresia: evidence for a virus-induced autoimmune disease. Semin Liver Dis. 2007;27(3):233\u201342.","journal-title":"Semin Liver Dis"},{"issue":"6","key":"2794_CR6","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1016\/S0022-3476(84)80076-1","volume":"105","author":"JH Glaser","year":"1984","unstructured":"Glaser JH, Balistreri WF, Morecki R. Role of reovirus type 3 in persistent infantile cholestasis. J Pediatr. 1984;105(6):912\u20135.","journal-title":"J Pediatr"},{"issue":"1","key":"2794_CR7","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1111\/j.1399-3046.2005.00257.x","volume":"9","author":"RB Fjaer","year":"2005","unstructured":"Fjaer RB, Bruu AL, Nordbo SA. Extrahepatic bile duct atresia and viral involvement. Pediatr Transplant. 2005;9(1):68\u201373.","journal-title":"Pediatr Transplant"},{"key":"2794_CR8","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1016\/j.cell.2020.10.048","volume":"183","author":"J Wang","year":"2020","unstructured":"Wang J, Xu Y, Chen Z, Liang J, Lin Z, Liang H, et al. Liver immune profiling reveals pathogenesis and therapeutics for biliary atresia. Cell. 2020;183:1867.","journal-title":"Cell"},{"issue":"1","key":"2794_CR9","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1203\/01.PDR.0000130480.51066.FB","volume":"56","author":"CL Mack","year":"2004","unstructured":"Mack CL, Tucker RM, Sokol RJ, Karrer FM, Kotzin BL, Whitington PF, et al. Biliary atresia is associated with CD4+ Th1 cell-mediated portal tract inflammation. Pediatr Res. 2004;56(1):79\u201387.","journal-title":"Pediatr Res"},{"issue":"12","key":"2794_CR10","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1007\/s00383-013-3421-6","volume":"29","author":"Y Yang","year":"2013","unstructured":"Yang Y, Liu YJ, Tang ST, Yang L, Yang J, Cao GQ, et al. Elevated Th17 cells accompanied by decreased regulatory T cells and cytokine environment in infants with biliary atresia. Pediatr Surg Int. 2013;29(12):1249\u201360.","journal-title":"Pediatr Surg Int"},{"issue":"3","key":"2794_CR11","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1172\/JCI200421153","volume":"114","author":"P Shivakumar","year":"2004","unstructured":"Shivakumar P, Campbell KM, Sabla GE, Miethke A, Tiao G, McNeal MM, et al. Obstruction of extrahepatic bile ducts by lymphocytes is regulated by IFN-gamma in experimental biliary atresia. J Clin Invest. 2004;114(3):322\u20139.","journal-title":"J Clin Invest"},{"issue":"6","key":"2794_CR12","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1084\/jem.20112741","volume":"209","author":"T Yokosuka","year":"2012","unstructured":"Yokosuka T, Takamatsu M, Kobayashi-Imanishi W, Hashimoto-Tane A, Azuma M, Saito T. Programmed cell death 1 forms negative costimulatory microclusters that directly inhibit T cell receptor signaling by recruiting phosphatase SHP2. J Exp Med. 2012;209(6):1201\u201317.","journal-title":"J Exp Med"},{"issue":"33","key":"2794_CR13","doi-asserted-by":"publisher","first-page":"11823","DOI":"10.1073\/pnas.0505497102","volume":"102","author":"J Wang","year":"2005","unstructured":"Wang J, Yoshida T, Nakaki F, Hiai H, Okazaki T, Honjo T. Establishment of NOD-Pdcd1\u2212\/\u2212 mice as an efficient animal model of type I diabetes. Proc Natl Acad Sci U S A. 2005;102(33):11823\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2794_CR14","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cellimm.2016.09.009","volume":"310","author":"MR Zamani","year":"2016","unstructured":"Zamani MR, Aslani S, Salmaninejad A, Javan MR, Rezaei N. PD-1\/PD-L and autoimmunity: a growing relationship. Cell Immunol. 2016;310:27\u201341.","journal-title":"Cell Immunol"},{"key":"2794_CR15","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3389\/fphys.2020.00023","volume":"11","author":"M Nitti","year":"2020","unstructured":"Nitti M, Furfaro AL, Mann GE. Heme oxygenase dependent bilirubin generation in vascular cells: a role in preventing endothelial dysfunction in local tissue microenvironment? Front Physiol. 2020;11:23.","journal-title":"Front Physiol"},{"issue":"10","key":"2794_CR16","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1016\/j.chembiol.2019.07.006","volume":"26","author":"C Vasavda","year":"2019","unstructured":"Vasavda C, Kothari R, Malla AP, Tokhunts R, Lin A, Ji M, et al. Bilirubin links Heme metabolism to neuroprotection by scavenging superoxide. Cell Chem Biol. 2019;26(10):1450\u201360 e7.","journal-title":"Cell Chem Biol"},{"issue":"22","key":"2794_CR17","doi-asserted-by":"publisher","first-page":"8650","DOI":"10.3390\/ijms21228650","volume":"21","author":"DT Tran","year":"2020","unstructured":"Tran DT, Jeong YY, Kim JM, Bae HB, Son SK, Kwak SH. The anti-inflammatory role of bilirubin on \u201ctwo-hit\u201d sepsis animal model. Int J Mol Sci. 2020;21(22):8650.","journal-title":"Int J Mol Sci"},{"issue":"8","key":"2794_CR18","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1111\/j.1440-1827.2007.02129.x","volume":"57","author":"T Oikawa","year":"2007","unstructured":"Oikawa T, Takahashi H, Ishikawa T, Hokari A, Otsuki N, Azuma M, et al. Intrahepatic expression of the co-stimulatory molecules programmed death-1, and its ligands in autoimmune liver disease. Pathol Int. 2007;57(8):485\u201392.","journal-title":"Pathol Int"},{"issue":"2","key":"2794_CR19","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1002\/hep.20334","volume":"40","author":"WW Wang","year":"2004","unstructured":"Wang WW, Smith DL, Zucker SD. Bilirubin inhibits iNOS expression and NO production in response to endotoxin in rats. Hepatology. 2004;40(2):424\u201333.","journal-title":"Hepatology."}],"container-title":["BMC Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-021-02794-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12887-021-02794-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-021-02794-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,16]],"date-time":"2021-07-16T01:04:18Z","timestamp":1626397458000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpediatr.biomedcentral.com\/articles\/10.1186\/s12887-021-02794-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,16]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2794"],"URL":"https:\/\/doi.org\/10.1186\/s12887-021-02794-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-385311\/v1","asserted-by":"object"}]},"ISSN":["1471-2431"],"issn-type":[{"value":"1471-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,16]]},"assertion":[{"value":"2 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Medical Ethics Committee of Guangzhou Women and Children\u2019s Medical Center approved the study procedures (ID:2019\u201321000). The implementations were in concordance with the International Ethical Guidelines for Research Involving Human Subjects as stated in the Helsinki Declaration. The legal guardians of all participants signed the informed contents. All animal experiments were approved by the Institutional Animal Care and Use Committee of Guangzhou Medical University, Guangzhou, China. The study was carried out in compliance with the ARRIVE guidelines (\n                      \n                      ).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written parental consents for the publication have been obtained.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no financial and non-financial conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"317"}}